In our search for guiding principles out of which to conduct therapy, we encounter two temptations: temptations of power and certainty. When therapists do not adequately account for the position of our clients, we fall prey to the temptation of certainty. When we attempt to impose corrections from such certainty, we fall victim to the temptation of power. Colonization occurs in therapy when our commitment to “expert knowledge” blinds us to the experience in the room. This paper offers suggestions for sidestepping power/certainty by constrating therapies of power and certainty with therapies of curiosity and empowernment.
Introduction:To identify factors associated with readmission and development of an equation predicting unsuccessful discharge to enable more effective targeting of resources, decrease burden on hospitals and improve quality of care for the patients.Methods: Prospective Observational study conducted over 12 months between November 2013 and November 2014 on patients readmitted to MAPU in last 28 days from the first index admission in MAPU. Demographic data (age, gender, race, diagnosis on admission and re-admission, social circumstances) was collected along with data on patient's ADL, performance status, length of stay, number of co-morbidities and medications.Results: Total number of patients studied was 179 with male to female ratio of 1:1.2 with mean age of 70.12 years. Of interest, 40% of people were either divorced or widowed. Around 70% of people were pensioners. 60% were current/reformed smokers and approximately half had history of moderate to heavy drinking. Significant proportion suffered from mood/anxiety disorders (40%). Most of the people were independent with activities of daily living and communication. But around half of the patients (48.6%) complained that pain limits their activity and nearly one-fifth had h/o falls. Around threefourth of patients were discharged on six or more medication on index admission with one-fourth of patients being discharged on opioids. Nearly half (48%) had high/very high Charlson's co-morbidity index with nearly two-thirds having more than two variables on Elixhauser index suggesting increased disease burden in this cohort. More than one-third (42%) had high LACE 1 score predisposing them to readmission. Most of the patients readmitted with the same diagnosis were admitted due to disease progression/complication despite optimum care. And most of the patients readmitted with different diagnosis were admitted due to new condition unrelated to the index admission. The relationship between re-admission status and other factors was tested with Chi-square tests for all categorical variables after dividing the cohort into two groups: one with ≤3 admissions and other with >3 admissions (86 vs 93 patients respectively). Significant relationship was found between number of re-admissions and LACE score, employment status, education and number of medications on discharge and high risk medications on discharge. A stepwise logistic regression with backward elimination found employment status, education, high risk medications as significant and LACE score almost significant predictors in the model.
Conclusions:Our high risk patient group included elderly frail pensioners with increased burden of chronic diseases, social isolation, mood disorders, poor education and polypharmacy with previous h/o readmissions. De-prescribing, better patient/carer education, proper assessment and management of functional needs including pain, disability and comorbidities with transitional care strategies integrating pre-discharge needs assessment with post-discharge care may reduce the readmission rat...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.